Form D · Other Technology
Leonardo Biosystems, Inc.
Houston, TX · CIK 0001492141
Offering snapshot reported May 18, 2010 · SEC filing
- Reported sold
- $1.25M Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1.25M Reported outside-investor minimum
- First sale
- May 3, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 18, 2010 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142228
Source: Form D, filed May 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Anzalone | Director, Executive |
| Mauro Ferrari | Director, Executive |
| Bruce Given | Executive |
| Mark Modzelewski | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
7000 Fannin Street 19 Th Floor
Houston, TX, 77030
Houston, TX, 77030